Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis
Authors:
- J. Sastre-GarrigaJSJ. Sastre-Garriga
- G. T. IngleGIG. T. Ingle
- D. T. ChardDCD. T. Chard
- Lí. Ramió-TorrentàLRLí. Ramió-Torrentà
- M. A. McLeanMMM. A. McLean
- D. H. MillerDMD. H. Miller
- A. J. ThompsonATA. J. Thompson
Open Access
- 1 April 2005
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 62 (4) , 569-573
Abstract
Changes in normal-appearing white matter (NAWM) in multiple sclerosis (MS) have been demonstrated early in the clinical course of the disease by a range of magnetic resonance (MR) techniques and are clinically relevant.1 The most pathologically specific of these techniques, proton MR spectroscopy (MRS), which estimates the concentration of a number of metabolites in vivo, has shown reduced N-acetyl-aspartate, a putative marker of axonal loss or dysfunction, in the NAWM of patients with MS.2 The use of short-echo MRS imaging (MRSI) together with more sophisticated quantification techniques3 makes it possible to determine the levels of other metabolites, such as myo-inositol and glutamate-glutamine, which could reflect other pathological processes, such as astrogliosis.Keywords
This publication has 17 references indexed in Scilit:
- Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brainCurrent Opinion in Neurology, 2002
- Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopyMultiple Sclerosis Journal, 2002
- The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM‐based segmentation methodologyJournal of Magnetic Resonance Imaging, 2002
- Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imagingJournal of Magnetic Resonance Imaging, 2002
- Quantitative analysis of short echo time1H-MRSI of cerebral gray and white matterMagnetic Resonance in Medicine, 2000
- Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosisNMR in Biomedicine, 2000
- 1 H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosisJournal of Neurology, 1999
- Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patientsBrain, 1999
- 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon lossBrain, 1995